CATEGORY: FDA – Regulatory
Do Women Need Testosterone?
Dr. Kathy Maupin and Brett Newcomb discuss the challenges that their practice faces as they try to apply the foremost research available to help their patients feel younger through testosterone replacement therapy. Women need and use testosterone for the same[...]
How the FDA and DEA Affect Healthcare
Dr. Kathy Maupin and Brett Newcomb discuss the role that the Food and Drug Administration plays in today's medical arena. They talk about how faulty policies and business interests can often keep patients from receiving optimal and effective treatment. This[...]
Senate Bill 959
Senate Bill 959, if passed, could limit or stop our access to bioidentical hormone pellet therapy. My practice and the health and comfort of my bioidentical hormone patients depends on the availability of pellets manufactured by compounding pharmacies. The US[...]
Senate Bill 959 Part 2
Your Bio-Identical Hormone Pellets are at Risk. Act Now to Stop Senate Bill 959 Senate Bill 959 is working its way through the Senate Health Education Labor and Pensions committee. This Bill is attempting to establish the authority for the[...]
Senate Bill 959 Part 1
Compounding Pharmacies and the Government In this podcast, Brett Newcomb and I are talking about Senate Bill 959, a bill before the Senate Health Education Labor and Pensions committee, chaired by Senator Tom Harkin. This is a fifty five page[...]
Obamacare Part 2
How the Insurance Companies Regulate and Control Medical Care Brett Newcomb and I continue our discussions about the state of the medical system in the United States today. We talk about how pharmacies work with insurance companies to fill (or[...]
Testosterone and the FDA
The Federal Drug Administration regulates testosterone as a treatment for symptoms of menopause. Download the transcription of this podcast. Episode 51 of the BioBalance Healthcast begins a discussion of how the Federal Drug Administration—or FDA—regulates drugs, and in particular, testosterone[...]